• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    XOMA Royalty Announces Tender Offer Closure for HilleVax

    GLOBENEWSWIRE

    HilleVax Enter into a Definitive Agreement to be Acquired by XOMA

    GLOBENEWSWIRE

    HilleVax Reports Q1 2025 Financial Results and Recent Progress

    GLOBENEWSWIRE

    HilleVax stock sink 80% as Norovirus Vaccine flunks phase 2 trial in infants

    FIERCE BIOTECH

    HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference

    GLOBENEWSWIRE

    HilleVax Announces Executive Management Appointment of Sean McLoughlin as COO

    GLOBENEWSWIRE

    HilleVax and Kangh Announce Exclusive License Agreement

    GLOBENEWSWIRE

    HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference

    GLOBENEWSWIRE

    HilleVax Reports Third Quarter 2023 Financial Results

    GLOBENEWSWIRE

    HilleVax to Present at Upcoming Investor Conferences

    GLOBENEWSWIRE

    HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Conference

    GLOBENEWSWIRE

    HilleVax Announces Closing of Public Offering of Common Stock

    GLOBENEWSWIRE

    HilleVax Announces Proposed Public Offering of Common Stock

    GLOBENEWSWIRE

    HilleVax Announces Pricing of Public Offering of Common Stock

    GLOBENEWSWIRE

    HilleVax Reports Second Quarter 2023 Financial Results

    GLOBENEWSWIRE

    HilleVax delays PhIIb norovirus data until mid-2024 over processing logistics

    ENDPTS

    HilleVax Reports First Quarter 2023 Financial Results

    GLOBENEWSWIRE

    HilleVax Announces Completion of Enrollment of NEST-IN1 Phase 2b Clinical Study

    GLOBENEWSWIRE

    HilleVax to Present at the 41st Annual J.P. Morgan Healthcare Conference

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.